Brief: ARS Pharmaceuticals Receives Favorable Decision From European Patent Office On Patent Related To Neffy® (Epinephrine Nasal Spray)

ARS Pharmaceuticals

08/10/2025 13:10

Oct 8 (Reuters) - ARS Pharmaceuticals Inc SPRY.O:

ARS PHARMACEUTICALS RECEIVES FAVORABLE DECISION FROM EUROPEAN PATENT OFFICE ON PATENT RELATED TO NEFFY® (EPINEPHRINE NASAL SPRAY)

ARS PHARMACEUTICALS : GLOBAL INTELLECTUAL PROPERTY PORTFOLIO RELATED TO NEFFY PROVIDES COVERAGE UNTIL AT LEAST 2039

Source text: ID:nGNX9hgVxy

Further company coverage: SPRY.O

 ((Reuters.Briefs@thomsonreuters.com;))